  SARS-CoV-2 has disrupted the life of billions of people around the world
since the first outbreak was officially declared in China at the beginning of
2020. Yet, important questions such as how deadly it is or its degree of spread
within different countries remain unanswered. In this work, we exploit the
`universal' growth of the mortality rate with age observed in different
countries since the beginning of their respective outbreaks, combined with the
results of the antibody prevalence tests in the population of Spain, to unveil
both unknowns. We validate these results with an analogous antibody rate survey
in the canton of Geneva, Switzerland. We also argue that the official number of
deaths over 70 years old is importantly underestimated in most of the
countries, and we use the comparison between the official records with the
number of deaths mentioning COVID-19 in the death certificates to quantify by
how much. Using this information, we estimate the fatality infection ratio
(IFR) for the different age segments and the fraction of the population
infected in different countries assuming a uniform exposure to the virus in all
age segments. We also give estimations for the non-uniform IFR using the
sero-epidemiological results of Spain, showing a very similar growth of the
fatality ratio with age. Only for Spain, we estimate the probability (if
infected) of being identified as a case, being hospitalized or admitted in the
intensive care units as function of age. In general, we observe a nearly
exponential growth of the fatality ratio with age, which anticipates large
differences in total IFR in countries with different demographic distributions,
with numbers that range from 1.82\% in Italy, to 0.62\% in China or even 0.14\%
in middle Africa.
